Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation

Liver Transplantation

Volumn 13, Issue 7, 2007, Pages 1039-1044

  Soliman, Thomas ^a   Hetz, Hubert ^a   Burghuber, Christoph ^a   Györi, Georg ^a   Silberhumer, Gerd ^a   Steininger, Rudolf ^a   Mühlbacher, Ferdinand ^a   Berlakovich, Gabriela A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CALCINEURIN INHIBITOR; CORTICOSTEROID DERIVATIVE; CREATININE; CYCLOSPORIN A; DEXAMETHASONE; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SURVIVAL; THERAPY DELAY; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

ADULT; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 34547588360     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21185     Document Type: Article

References (20)

1. Perry I, Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Immunol 2005;139:2-10.
2. Steininger R, Muhlbacher F, Hamilton G, Langle F, Gnant M, Popow T, et al. Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation. Transplant Proc 1991;23:2269-2271.
3. Furukawa H, Todo S. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. Transplant Proc 2004;36(2 Suppl):274S-284S.
4. Moser MA. Options for induction immunosuppression in liver transplant recipients. Drugs 2002;62:995-1011.
5. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom. M, Kwo P, et al. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transpl 2004;10:404-407.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 199916;130:461-470.
7. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
8. Ducloux D, Kazory A, Challier B, Coutet J, Bresson-Vautrin C, Motte G, et al. Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation 200415;77: 1029-1033.
9. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:153-154.
10. MeVicar JP, Kowdley KV, Emond MJ, Barr D, Marsh CL, Carithers RL, et al. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. Clin Transplant 1997;11:328-33.
11. Wall WJ. Use of antilymphocyte induction therapy in liver transplantation. Liver Transpl Surg 1999;5(4 Suppl 1):64-70.
12. Kamar N, Borde JS, Sandres-Saune K, Sue B, Barange K, Cointault O, et al. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C. Clin Transplant 2005;19:83-89.
13. Schulak J, May E, Post A, Fasola C, Mulligan D, Sterling R. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Transplant Proc 1997; 29:555-556.
14. Guitard J, Cointault O, Kamar N, Muscari F, Lavayssiere L, Sue B, et al. Acute renal failure following liver transplantation with induction therapy. Clin Nephrol 2006;65: 103-112.
15. Lin CC, Chuang FR, Lee CH, Wang CC, Chen YS, Liu YW, et al. The renal-sparing effect of basiliximab in adult living donor liver transplantation. Liver Transpl 2005;11:1258-1264.
16. Tchervenkov JI, Tzimas GN, Cantarovich M, Barkun JS, Metrakos P. The impact of thymoglobulin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplant: a retrospective analysis of 298 consecutive patients. Transplant Proc 2004;36:1747-1752.
17. Mueller TF. Thymoglobulin: an immunologic overview. Curr Opin Organ Transpl 2003;4:305-512.
18. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 200315;76:798-802.
19. Neuhaus P, Klupp J, Langrehr JM, Neumann U, Gebhardt A, Pratschke J, et al. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial. Transplantation 2000;69:2343-2353.
20. Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997;80:1141-1150.